The firm is discontinuing its CHIRON and THETIS trials after lackluster data and is planning for potential third-party deals and workforce layoffs.

A SCHOOLGIRL has shared the “devastating” reality of cancer in a heartbreaking home video. Raw and heartbreaking footage shows Asha Patel pulling clumps of hair out in tears before ...

Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...

The researchers demonstrated that NUDCD3 mutations impede a crucial gene-rearranging mechanism known as V(D)J recombination ...

Achilles Therapeutics has announced it will discontinue its tumor-infiltrating lymphocyte (TIL)-based clonal neoantigen T ...

T cells are our first line of defense against cancer, but the battle tends to exhaust them. Now, scientists have found a way ...

Vallina, from the CRIS Immuno-Oncology Unit, in Madrid (Spain), explains that a new approach provides 'trained troops' of ...

Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...